AstraZeneca Pharma India Limited Share Price and Company Fundamentals
Last traded: Today at 3:37 AM
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and distributes pharmaceutical products in India and internationally. It manufactures and sells medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, QTERN, Symbicort, LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brands. The company offers products in the areas of cardiovascular, renal, metabolic, oncology, respiratory, inflammation, and autoimmunity diseases. It also provides clinical trial services. The company was incorporated in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Key Metrics
PE ratio
109.40
PB ratio
13.18
Dividend yield
0.30%
Beta
0.47
Market cap
-
Enterprise value
-
Company profile
| Industry / Sector | Drug Manufacturers—Specialty & Generic / Healthcare |
|---|---|
| Website | https://www.astrazeneca.in |
| Mailing address | Manyata Embassy Business Park Block N1, 12th Floor Rachenahalli Outer Ring Road Bengaluru 560045 India |
| Phone / Fax | 91 80 6774 8000 / 91 80 6774 8557 |
Dividends
Dividend yield
0.30%
Dividend amount
₹8.00
Payout ratio
8.12%
AstraZeneca Pharma India Limited paid ₹8.00 dividend and the ex-dividend date was 07 July 2022.The dividend payout ratio is 8.12%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ASTRAZEN dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
ASTRAZEN's forward dividend amount is ₹16 and the forward dividend yield is 0.59%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of Jul 2022, following are the company executives and directors listed on AstraZeneca Pharma India Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Gagandeep Singh Bedi | MD, Country Pres & Exec. Director | 50 | 49.61M |
| Mr. Rajesh Marwaha | CFO & Exec. Director | 58 | 27.45M |
| Mr. Pratap Rudra Bhuvanagiri | Company Sec., Legal Counsel & Compliance Officer | ||
| Ms. Smita Saha | VP of HR | 51 | |
| Mr. Richard Cheeseman | Head of Engineering & Facilities | 48 | |
| Mr. Vimlesh Maheshwari | Fin. Controller | ||
| Dr. K. R. Premnath Shenoy | Director of Regulatory | 65 | |
| Mr. Ramesh Kadaba Venkatapathi | Director of Quality Assurance & Technical Services | 69 | |
| Dr. Paurus Mehelli Irani | Global Medical Affairs Leader - Infection | 54 | |
| Mr. Rajeev Nagi | VP of Institutions & International Bus. | 51 |
Profitability and management effectiveness
Profit margin
7.65%
Operating margin
8.59%
Return on assets
5.30%
Return on equity
12.73%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of AstraZeneca Pharma India Limited is and its enterprise value is .
The ASTRAZEN's stocks Beta value is 0.47 making it 53% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Frequently Asked Questions
1. What is AstraZeneca Pharma India Limited's Stock Symbol?
AstraZeneca Pharma India Limited trades on NSE under the ticker symbol "ASTRAZEN".
2. What is AstraZeneca Pharma India Limited's stock price today?
One share of ASTRAZEN stock can currently be purchased for approximately ₹2741.6.
3. How can I contact AstraZeneca Pharma India Limited?
AstraZeneca Pharma India Limited's mailing address is Manyata Embassy Business Park Block N1, 12th Floor Rachenahalli Outer Ring Road Bengaluru 560045 India. The company can be reached via phone at 91 80 6774 8000.
4. What is AstraZeneca Pharma India Limited's official website?
The official website of AstraZeneca Pharma India Limited is https://www.astrazeneca.in.